About Index Trending news
Analyze
Pricing
BrainStorm Cell Therapeutics

BrainStorm Cell Therapeutics

Work at BrainStorm Cell Therapeutics? Add yourself to this profile

BrainStorm Cell Therapeutics

Biotechnology company developing first-of-its-kind, autologous stem cell therapies for the treatment of neurodegenerative diseases such as ALS, MS, PD.
Edit Profile
More info

Elsewhere

Contributors to this profile

Also headquartered in New York

Verizon Verizon IBM IBM HBO HBO Kickstarter Kickstarter Wired Wired AOL AOL Tumblr Tumblr Time Warner Time Warner Goldman Sachs Goldman Sachs The New York Times The New York Times

Companies in the same industry

Seattle Genetics Seattle Genetics Immune Design Immune Design MetaStat Inc. MetaStat Inc. Alder Biopharmaceuticals Inc. (Nasdaq: ALDR) Alder Biopharmaceuticals Inc. (Nasdaq: ALDR) Hookipa Biotech Hookipa Biotech Theranica Theranica Arcturus Therapeutics Arcturus Therapeutics Prosensa Prosensa Lysosomal Therapeutics Lysosomal Therapeutics Biscayne NeuroTherapeutics Biscayne NeuroTherapeutics

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 4
Add info
13 Jun 2017
$2,100,000
Grant
Israel Innovation Authority

Brainstorm lands $2.1m Israeli grant for NurOwn stem cell therapy

Drug Delivery Business
24 Jul 2014
$5,000,000
Grant
13 Jun 2014
$10,500,000
Post-IPO equity
09 May 2014
$1,632,689
Venture capital